Bioimpedance Analyzers Market is expected to increase at a compound annual growth rate (CAGR) of 12.8% from 2025 to 2035
The Bioimpedance Analyzers market was estimated to be worth USD 578
million in 2024 and is expected to grow at a compound annual growth rate (CAGR)
of 12.8% to reach USD 1085.1 million in 2035. Bioimpedance analyzers enable
people and medical professionals make well-informed decisions by offering
comprehensive insights into the body's measurements. The market is sustainable
and expanding since it is in line with the healthcare industry.
Bioimpedance
analyzers, sometimes referred to as bioelectrical impedance analyzers (BIA),
are noninvasive instruments that use a little electrical current to detect the
voltage across the body to determine body composition. The volume of
electrolytic fluid in the body is inversely correlated with the observed
resistance. Total body water, extracellular fluid, lean body mass, fat mass,
percent of mass, body cell mass, and intercellular water can all be calculated.
Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/bioimpedance-analyzers-market
GROWTH
DRIVERS
The need for
precise body composition measurement is fueled by the rising prevalence of
obesity and lifestyle diseases including diabetes and cardiovascular disorders.
The World Health Organization (WHO) reports that 16% of persons worldwide who
were 18 years of age or older were obese in 2022, more than doubling the
prevalence from 1990. There are more than 1 billion individuals in the world,
comprising at least 120 million children and adolescents and more than 670
million adults.
According to
WHO forecasts, an additional 167 million individuals will become less healthy
by 2025 as a result of being overweight or obese. One of the main factors
driving the market is the increasing awareness of fitness and health; as more
people become health-conscious, the need for instruments like bioimpedance
analyzers increases. According to Statista, the total revenue is anticipated to
expand at an annual pace of around 9.61% between 2022 and 2027, resulting in a
predicted market volume of USD 6.7 billion by 2027.
MARKET
SEGMENTATION:
· By
Device Type– Single frequency bioimpedance analyzers, dual-frequency
bioimpedance analyzers and multiple-frequency bioimpedance analyzers
· By
Application – Segmental body measurement and whole-body measurement
· By
Modality - Wire and wireless bioimpedance analyzers
· By
End-User- Hospitals & Clinics, Fitness and wellness centers, home user
settings and others
· By
Region- North America, Europe, Asia Pacific, The Middle East and
Africa, South America
Global
Key Players:
· Tanita
Corporation
· Seca
GmbH & Co. KG
· Maltron
International Ltd.
· Akern
· RJL
Systems
· Accuniq
(SELVAS Healthcare)
· InBody
Co., Ltd.
· Bodystat
Ltd.
· Omron
Corporation
· Charder
Medical
For More Information about this Report @
https://www.xresearch.biz/shop/bioimpedance-analyzers-market
About Us: -
xResearch is a market research and consulting
organization that uses unique data, expert analysis, and new technologies to
create trusted intelligence on industries. Our research is focused on
delivering an informed and impartial view on essential market data of industry,
and it is primarily driven by an in-depth study covering the following
parameters: Market Sizing and Forecasting, Market Segmentation, Competitive
Analysis, Strategic Assessment and Business Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Websites: https://www.xresearch.biz/

Comments
Post a Comment